Latest Global Markets News

NeuroScientific Biopharmaceuticals has initiated treatment of its fourth patient under the Special Access Scheme for StemSmart™, progressing towards a Phase 2 trial targeting severe Crohn’s disease.

OFX Group reported a 5.6% decline in net operating income for 1H26 amid macroeconomic challenges but showcased strong progress in its OFX 2.0 platform transition and strategic investments aimed at long-term growth.

Eden Innovations has successfully raised $4.35 million through a placement of shortfall securities, marking a key step in its financial reconstruction and global expansion plans.

Atomos Limited has upgraded its FY26 earnings guidance, forecasting significant sales growth and a return to EBITDA profitability driven by strong demand and a revamped sales strategy.

Lode Resources has extended the Montezuma Silver & Antimony deposit in Tasmania, revealing high-grade mineralisation over a significant strike and depth. New drilling results show promising grades, supporting ongoing exploration and metallurgical testing.

Compumedics has landed a $4.9 million magnetoencephalography (MEG) system order from Beijing Normal University, pushing total MEG sales in China to $25 million and reinforcing its leadership in the Asian neuro-imaging market.

Memphasys Limited has successfully raised over $1.1 million through a pro-rata entitlement offer to accelerate the commercialisation of its innovative Felix™ sperm selection system, targeting key regulatory approvals and market expansion.

Macquarie Group reported a 3% rise in net profit to A$1.655 billion for the half year ended September 2025, driven by strong growth in asset management and capital divisions. The group also extended its A$2 billion share buyback program and declared a solid interim dividend.

Perpetual Resources has certified exceptionally high caesium grades up to 28.3% Cs2O at its Morro Grande prospect in Brazil’s Lithium Valley, reinforcing its potential as a major critical minerals source.

Macquarie Group Limited reported a 3% increase in net profit to A$1.655 billion for the half year ended 30 September 2025, driven by robust performances in its asset management and capital segments. The Group’s diversified funding and strong capital position underpin its strategic growth and climate finance initiatives.

Macquarie Group Limited reported a 3% increase in half-year profit to $1.655 billion, driven by growth across its asset management, banking, commodities, and capital markets divisions. The group maintains robust capital and liquidity positions despite margin pressures and regulatory challenges.

Macquarie Group reported a solid half-year profit increase despite a sequential dip, boosted by strong asset management and capital markets performance. The group also extended its share buyback and declared a steady interim dividend.